Share Statistics
| Avg Vol (3 month) 3 | 2.11M |
|---|---|
| Shares Outstanding 5 | 246.81M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 86.44M |
| % Held by Insiders 1 | 61.91% |
Similarly, Does BioNTech pay a dividend?
BIONTECH SE (NASDAQ: BNTX) does not pay a dividend.
Why is BNTX stock up? The gain continued momentum from earlier this week with COVID-19 cases soaring in China and Europe. And on Tuesday, BioNTech and its big partner, Pfizer ( PFE -2.25% ), applied for Food and Drug Administration authorization of an additional booster dose of their COVID vaccine for adults 65 or older.
Thereof, What ETF has BioNTech?
BioNTech SE Sponsored ADR is a company in the U.S. stock market and it is a holding in 31 U.S.-traded ETFs. BNTX has around 2.1M shares in the U.S. ETF market. The largest ETF holder of BNTX is the iShares Biotechnology ETF (IBB), with approximately 1.22M shares.
When did BioNTech go public?
BioNTech went public in October 2019.
Does Moderna have a dividend?
MODERNA (NASDAQ: MRNA) does not pay a dividend.
Is Novavax a dividend stock?
Novavax (NASDAQ: NVAX) does not pay a dividend.
Is BioNTech a good investment?
If you’re an investor who typically invests in biotech stocks and is comfortable with the risks that they entail, I’d say that buying BioNTech today isn’t a terrible decision. In the long run, its research and development activity should pay off, and it’s in no great hurry for its pipeline projects to bear fruit.
Which ETF holds Crispr?
ETFs with the most CRSP Exposure
| Ticker | Fund Name | % Allocation |
|---|---|---|
| XDNA | Kelly CRISPR & Gene Editing Technology ETF | 11.23% |
| GNOM | Global X Genomics & Biotechnology ETF | 4.05% |
| ARKG | ARK Genomic Revolution ETF | 3.52% |
| ARKK | ARK Innovation ETF | 3.48% |
Is idna a good ETF?
IDNA is rated a 5 out of 5.
Is there a Crispr ETF?
Here are the top five ETFs that focus on CRISPR gene editing.
…
Best CRISPR and gene-editing ETFs.
| ETF | Expense Ratio |
|---|---|
| ARK Genomic Revolution ETF (NYSEMKT:ARKG) | 0.75% |
| Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) | 0.5% |
• 18 déc. 2021
Is BioNTech listed?
BioNTech Announces Commencement of Initial Public Offering
BioNTech has applied to list its ADSs on the Nasdaq Global Select Market under the symbol “BNTX.”
Is BioNTech on the stock exchange?
BioNTech SE BNTX:NASDAQ.
When did Moderna go public?
When did Moderna go public? What was the price? Moderna, Inc. began trading on the Nasdaq Global Select Market on December 7, 2018. The initial price was $23.00 per share.
Does Mrna pay a dividend?
Historical dividend payout and yield for Moderna (MRNA) since 1971. The current TTM dividend payout for Moderna (MRNA) as of March 25, 2022 is $0.00. The current dividend yield for Moderna as of March 25, 2022 is 0.00%.
What is Netflix dividend?
Historical dividend payout and yield for Netflix (NFLX) since 1971. The current TTM dividend payout for Netflix (NFLX) as of April 14, 2022 is $0.00. The current dividend yield for Netflix as of April 14, 2022 is 0.00%.
Which stock has the highest dividend?
Dividend stocks can be a great choice for investors looking for regular income.
…
25 high-dividend stocks.
| Symbol | Company Name | Dividend Yield |
|---|---|---|
| CVX | Chevron Corp | 3.48% |
| PFG | Principal Financial Group Inc | 3.48% |
| DLR | Digital Realty Trust Inc | 3.44% |
| HAS | Hasbro Inc. | 3.41% |
• 1 avr. 2022
Is Novavax publicly traded?
Common Stock (NVAX)
Is BNTX a strong buy?
Out of 9 analysts, 2 (22.22%) are recommending BNTX as a Strong Buy, 1 (11.11%) are recommending BNTX as a Buy, 6 (66.67%) are recommending BNTX as a Hold, 0 (0%) are recommending BNTX as a Sell, and 0 (0%) are recommending BNTX as a Strong Sell. What is BNTX’s earnings growth forecast for 2022-2024?
Is BioNTech a hold?
BioNTech has received a consensus rating of Hold. The company’s average rating score is 2.38, and is based on 5 buy ratings, 8 hold ratings, and no sell ratings.
Why is Pfizer stock going down today?
Pfizer CEO Albert Bourla talks. Pfizer shares dropped sharply after the company’s 2022 sales guidance appeared to fall short of expectations. The guidance that Pfizer (ticker: PFE) presented, however, doesn’t take into account future sales of Pfizer’s Covid-19 vaccine and antiviral, but only sales already made.
Join TheMoney.co community and don’t forget to share this post !